These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6361850)

  • 1. Nitroimidazoles as chemotherapeutic agents.
    Nair MD; Nagarajan K
    Prog Drug Res; 1983; 27():163-252. PubMed ID: 6361850
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infections.
    Goldman P
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():23-33. PubMed ID: 6749793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trichomonas vaginalis: treatment and resistance to nitroimidazoles].
    Vázquez F; José García M; Pérez F; Palacio V
    Enferm Infecc Microbiol Clin; 2001 Mar; 19(3):114-24. PubMed ID: 11333589
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative relationship between structure and mutagenic activity in a series of 5-nitroimidazoles.
    Biagi GL; Barbaro AM; Guerra MC; Cantelli Forti G; Aicardi G; Borea PA
    Teratog Carcinog Mutagen; 1983; 3(5):429-38. PubMed ID: 6139889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and various physico-chemical properties of 1-(2-hydroxy-3-alkoxypropyl)-4-nitroimidazoles].
    Suwiński J; Salwińska E; Watras J; Wideł M
    Acta Pol Pharm; 1978; 35(5):529-35. PubMed ID: 742378
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5-nitroimidazoles.
    Walsh JS; Wang R; Bagan E; Wang CC; Wislocki P; Miwa GT
    J Med Chem; 1987 Jan; 30(1):150-6. PubMed ID: 3543363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New derivatives of 5-nitroimidazole: synthesis and antiparasitic activity.
    Alcalde E; Maños L; Dinares I; Valls N; Elguero J; Escario JA; Martinez AR; Igea A; Osuna A; Ruiz-Perez LM
    Farmaco; 1989 Nov; 44(11):1095-107. PubMed ID: 2701965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New chemotherapeutic nitroheterocycles active against 5-nitroimidazole-resistant strains of trichomonads.
    Meingassner JG; Nesvadba H; Mieth H
    Arzneimittelforschung; 1981; 31(1):6-8. PubMed ID: 6971111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity.
    Zhang X; Su ZF; Ballinger JR; Rauth AM; Pollak A; Thornback JR
    Bioconjug Chem; 2000; 11(3):401-7. PubMed ID: 10821657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis.
    Rossignol JF; Maisonneuve H; Cho YW
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):63-72. PubMed ID: 6698665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity.
    Goldman P; Koch RL; Yeung TC; Chrystal EJ; Beaulieu BB; McLafferty MA; Sudlow G
    Biochem Pharmacol; 1986 Jan; 35(1):43-51. PubMed ID: 3753580
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-cytotoxicity relationships of nitroimidazoles in an in vitro system.
    Edwards DI; Knox RJ; Knight RC
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):791-3. PubMed ID: 7050045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Alkyl-2-nitroimidazol-5-yl derivatives. I.
    Cavalleri B; Volpe G; Pallanza R
    Arzneimittelforschung; 1975 Feb; 25(2):148-52. PubMed ID: 235267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Azoles. 27. Nitroimidazole derivatives, their antibacterial and fungicidal activity and electron affinity].
    Zaprutko L; Gajdziński M; Michalska W; Pietkiewicz K; Lutomski K; Lukaszewski Z; Wrzeciono U
    Pharmazie; 1989 Dec; 44(12):817-20. PubMed ID: 2635318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiprotozoal activity of 1-(3-chloro-2-hydroxypropyl)-substituted nitroimidazoles.
    Hoffer M; Grunberg E
    J Med Chem; 1974 Sep; 17(9):1019-20. PubMed ID: 4370421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Single-dose treatment with simplotan 500--progress in the therapy of urogeintal trichomoniasis].
    Wimmer R
    Z Allgemeinmed; 1975 Jun; 51(16):769-70. PubMed ID: 1226806
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract]   [Full Text] [Related]  

  • 18. 1-Alkyl-2-nitroimidazol-5-yl derivatives II. N-substituted nitrones.
    Cavalleri B; Ballotta R; Arioli V
    Arzneimittelforschung; 1975 Mar; 25(3):338-40. PubMed ID: 239726
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoxic cell radiosensitizers--chemical aspects and in vitro models.
    Wardman P
    Strahlentherapie Sonderb; 1978; 75():20-6. PubMed ID: 555049
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethidium bromide induced mutation of yeast mitochondria: complete transformation of cells into respiratory deficient non-chromosomal "petites".
    Slonimski PP; Perrodin G; Croft JH
    Biochem Biophys Res Commun; 1968 Feb; 30(3):232-9. PubMed ID: 5647224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.